2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1679990584 MD
Verify on CMS →

ANU THEKKUMKATTIL, MD

Endocrinology, Diabetes & Metabolism Physician in WEST PALM BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
679
Medicare Part D claims · 162 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.8268/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$472.35
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ANU THEKKUMKATTIL, MD reported a CMS MIPS final score of 96.8268/100 — above the 83.1 national average — and filed 679 Medicare Part D claims in 2023.

96.8268/100
MIPS score · +14 vs avg
679
Part D claims, 2023
45%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANU THEKKUMKATTIL, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

97 Top 17% higher than 83% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ANU THEKKUMKATTIL, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANU THEKKUMKATTIL, MD?

High performer (top quartile)

NPI registry status

Active

Issued 03/28/2014

NPI 1679990584

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

679 74% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

96.8268/100 13.726800000000011% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

ANU THEKKUMKATTIL, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
96.8268/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 96.8268/100 vs national avg 83.1

0%100%National avg83%96.8%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 96.8268/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANU THEKKUMKATTIL, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 625 N FLAGLER DR STE 200, WEST PALM BEACH, FL, 33401, with a listed phone of (561) 268-2000. NPI 1679990584 was issued on 03/28/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what THEKKUMKATTIL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 679 prescription claims written by this provider, covering 162 Medicare beneficiaries and totaling roughly $402K in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.8268/100 for the 2023 performance year (Quality 86.1113), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

625 N FLAGLER DR STE 200
WEST PALM BEACH, FL 33401

Provider Details

NPI 1679990584
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 03/28/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.8268
Final Score
Avg: 83.1
86.1113
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where ANU THEKKUMKATTIL, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF MIAMI
DEERFIELD BEACH, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANU THEKKUMKATTIL, MD. Source: openpaymentsdata.cms.gov.

Total received

$472

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ANU THEKKUMKATTIL, MD. To verify ANU THEKKUMKATTIL, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ANU THEKKUMKATTIL, MD — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 679 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

679
Total Claims
$402K
Total Drug Cost
162
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,577
Total Day Supply
46,574
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$391K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
68.9 years
Avg HCC Risk Score
2.05
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANU THEKKUMKATTIL, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ozempic
Semaglutide
96
Levothyroxine Sodium
84
Metformin Hcl Er
Metformin Hcl
41
Metformin Hcl
40
Trulicity
Dulaglutide
38
Jardiance
Empagliflozin
36
Glimepiride
18
Hydrocortisone
18
Mounjaro
Tirzepatide
17
Atorvastatin Calcium
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ANU THEKKUMKATTIL, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ANU THEKKUMKATTIL, MD's 679 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as THEKKUMKATTIL.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANU THEKKUMKATTIL, MD's specialty?
ANU THEKKUMKATTIL, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in WEST PALM BEACH, Florida. Credentials: MD.
How much does ANU THEKKUMKATTIL, MD prescribe under Medicare Part D?
In 2023, ANU THEKKUMKATTIL, MD wrote 679 Medicare Part D claims totaling $402K in drug costs for 162 beneficiaries.
What is ANU THEKKUMKATTIL, MD's Medicare quality score?
ANU THEKKUMKATTIL, MD has a CMS MIPS Final Score of 96.8268/100 (Quality: 86.1113). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANU THEKKUMKATTIL, MD located?
ANU THEKKUMKATTIL, MD is located at 625 N FLAGLER DR STE 200, WEST PALM BEACH, FL, 33401. Phone: (561) 268-2000.
What is ANU THEKKUMKATTIL, MD's NPI number?
ANU THEKKUMKATTIL, MD's National Provider Identifier (NPI) is 1679990584, issued on 03/28/2014.
Does ANU THEKKUMKATTIL, MD prescribe more brand-name or generic drugs?
ANU THEKKUMKATTIL, MD's prescribing is 55% brand-name and 45% generic drugs by claim count, with $391K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ANU THEKKUMKATTIL, MD prescribe most often?
Based on 2023 Medicare Part D data, ANU THEKKUMKATTIL, MD's most frequently prescribed drugs include Ozempic, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANU THEKKUMKATTIL, MD accept Medicare?
ANU THEKKUMKATTIL, MD appears in CMS Medicare data with 679 Part D claims and 162 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANU THEKKUMKATTIL, MD's credentials?
ANU THEKKUMKATTIL, MD's NPI is 1679990584 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology